Skip to content

Investigating Transcranial Direct Current Stimulation (tDCS) in Accelerating Learning in a Healthy Older Population

Investigating Transcranial Direct Current Stimulation (tDCS) in Accelerating Learning in a Healthy Older Population

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03467698
Enrollment
30
Registered
2018-03-16
Start date
2018-02-21
Completion date
2022-10-21
Last updated
2024-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Associative Memory in Healthy Subjects

Keywords

Aging, Memory, Associative learning, transcranial direct current stimulation

Brief summary

The overall objective of this study is to explore whether transcranial Direct Current Stimulation (tDCS) can accelerate associative learning and boost associative memory in healthy subjects.

Detailed description

The overall objective of this study is to explore whether transcranial Direct Current Stimulation (tDCS) can accelerate associative learning and boost associative memory in healthy subjects. The aim of this study is to investigate the effects of transcranial Direct Current Stimulation (tDCS) stimulation during a verbal paired-associate learning task to determine if tDCS may be used as a way to enhance brain plasticity during an associative memory task, and to accelerate learning and to optimize associative memory performance. We hypothesize that participants who receive tDCS stimulation will improve their associative memory performance.

Interventions

DEVICEActive tDCS

Real stimulation

DEVICESham tDCS

Sham stimulation

Sponsors

The University of Texas at Dallas
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Outcomes Assessor)

Intervention model description

Participants will be randomly assigned to one of two groups: (1) active tDCS (2) Sham tDCS.

Eligibility

Sex/Gender
ALL
Age
55 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

1. Age between 55 and 75 2. Currently not using any medication contradicting with tDCS 3. Native English speaker 4. Capable of understanding and signing an informed consent

Exclusion criteria

1. Acquainted with the Swahili language or culture 2. Severe disease 3. Mental illness 4. Cardiac history 5. History of severe head injuries 6. History of epileptic insults 7. Any implanted devices such as pace maker, neurostimulator 8. Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
A Computerized Verbal Paired-associate Memory Task Will be Used to Assess Memory Performance.Memory performance changes will be assessed in two different visits. First assessment (baseline) on visit 1 (learning), then one-week after during visit 2 (memory)Memory performance scores recorded in the computerized verbal paired-associate memory test during each visit will be compared between the two groups (active tDCS and sham tDCS).

Countries

United States

Participant flow

Participants by arm

ArmCount
Active tDCS
active HD-tDCS will be administered Active tDCS: Real stimulation
15
Sham tDCS
sham HD-tDCS will be administered Sham tDCS: Sham stimulation
15
Total30

Baseline characteristics

CharacteristicSham tDCSTotalActive tDCS
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
6 Participants14 Participants8 Participants
Age, Categorical
Between 18 and 65 years
9 Participants16 Participants7 Participants
Age, Continuous64.667 years
STANDARD_DEVIATION 5.78
64.60 years
STANDARD_DEVIATION 5.68
64.533 years
STANDARD_DEVIATION 5.58
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants1 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
0 Participants2 Participants2 Participants
Race (NIH/OMB)
More than one race
1 Participants1 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
13 Participants26 Participants13 Participants
Region of Enrollment
United States
15 participants30 participants15 participants
Sex: Female, Male
Female
2 Participants11 Participants9 Participants
Sex: Female, Male
Male
13 Participants19 Participants6 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 150 / 15
other
Total, other adverse events
0 / 150 / 15
serious
Total, serious adverse events
0 / 150 / 15

Outcome results

Primary

A Computerized Verbal Paired-associate Memory Task Will be Used to Assess Memory Performance.

Memory performance scores recorded in the computerized verbal paired-associate memory test during each visit will be compared between the two groups (active tDCS and sham tDCS).

Time frame: Memory performance changes will be assessed in two different visits. First assessment (baseline) on visit 1 (learning), then one-week after during visit 2 (memory)

ArmMeasureGroupValue (MEAN)Dispersion
Active tDCSA Computerized Verbal Paired-associate Memory Task Will be Used to Assess Memory Performance.Visit 2 - memory38.036 percentage of words learned/rememberedStandard Error 4.458
Active tDCSA Computerized Verbal Paired-associate Memory Task Will be Used to Assess Memory Performance.Visit 1 - learning52.93 percentage of words learned/rememberedStandard Error 25.87
Sham tDCSA Computerized Verbal Paired-associate Memory Task Will be Used to Assess Memory Performance.Visit 2 - memory24.65 percentage of words learned/rememberedStandard Error 3.458
Sham tDCSA Computerized Verbal Paired-associate Memory Task Will be Used to Assess Memory Performance.Visit 1 - learning58.93 percentage of words learned/rememberedStandard Error 24.88

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026